Perspectivas para o desenvolvimento da cadeia farmacêutica brasileira diante do enfrentamento da Covid-19

Abstract

The emergence of the Covid-19 pandemic highlighted the importance of a comprehensive look at the health area and expanded the consensus on the strategic relevance of the industrial health complex for the country's development. Despite the growth of the pharmaceutical industry in recent decades, commercial deficits are significant and the capacity for innovation is still fragile. Advances have been observed with the creation of new institutions and advances in the incorporation of skills by the companies, especially in the biotechnology field. The effort to develop new diagnostics tests, vaccines and drugs against Covid-19 can contribute to leverage the country's capacity for innovation. The coordination of public policies is essential for the continuity and success of ongoing efforts. BNDES can contribute to this transformation offering appropriate instruments to support the various stages of research, development and innovation in health.